Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Health

India’s Finance Minister Highlights Commitment to Preventing Cervical Cancer Through Vaccination Program

Cervical cancer is a prevalent issue affecting women globally. According to the World Health Organisation (WHO), an estimated 604,000 women were diagnosed with cervical cancer in 2020, with approximately 342,000 succumbing to the disease. Despite its common occurrence, cervical cancer is highly treatable, especially when detected early.

In her address during the presentation of the Interim Budget for 2024, Finance Minister Nirmala Sitharaman highlighted the government’s commitment to promoting vaccination for girls aged 9 to 14 years to prevent cervical cancer. The introduction of an India-made quadrivalent vaccine as a twin-dose regimen for adolescent girls was also proposed by the Centre last year.

Causes of Cervical Cancer

The primary cause of cervical cancer is the human papillomavirus (HPV), responsible for 99% of cases. HPV is a common sexually transmitted infection that affects the throat, genitals, and skin. While most individuals may contract the virus without displaying symptoms, persistent infection can lead to the development of abnormal cells, potentially progressing to cancer.

Factors such as young motherhood, use of hormonal contraceptives, smoking, and other sexually transmitted infections elevate the risk of cervical cancer. Additionally, weakened immune systems can expedite the progression of abnormal cells to cancer, shortening the typical 15-20 year period to 5-10 years.

Symptoms and Treatment

Common symptoms associated with cervical cancer, as identified by the WHO, include unusual bleeding between periods, after menopause, or post-sexual intercourse, as well as increased or foul-smelling vaginal discharge. Other indicators encompass persistent pain in the back, legs, or pelvis, weight loss, fatigue, loss of appetite, vaginal discomfort, and swelling in the legs.

Early diagnosis through medical examination is crucial for confirming the presence of cervical cancer. Treatment options may involve surgery, radiation therapy, chemotherapy, or a combination of these approaches, depending on the stage and progression of the disease.

LEAVE A RESPONSE

Your email address will not be published. Required fields are marked *